≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Carbimazole or st.post thyredectomy, condition for graves disease

PheWeb

GRAVES_COND

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Operations: NOMESCO codes ^BA
Medicine purchases: ATC H03BB01

12361

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

10883

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

10883

diagram downward connector

Include endpoints None

10883

diagram downward connector
GRAVES_COND

Extra metadata

First used in FinnGen datafreeze DF7

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 10883 8628 2255
Unadjusted prevalence (%) 3.06 4.35 1.43
Mean age at first event (years) 54.01 52.71 58.96

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.83 [1.38, 2.42] 2.3e-5 541
15 years 0.01 1.09 [0.85, 1.41] 5.0e-1 234
5 years 0.00 2.50 [1.98, 3.16] 1.6e-14 167
1 year 0.00 6.21 [4.68, 8.24] 1.5e-36 77

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: GRAVES_COND – Carbimazole or st.post thyredectomy, condition for graves disease
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carbimazole or st.post thyredectomy, condition for graves disease
after Carbimazole or st.post thyredectomy, condition for graves disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carbimazole or st.post thyredectomy, condition for graves disease

↥